Professional and Linguistic Assessments Board (PLAB) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the PLAB Test with interactive quizzes and comprehensive study materials. Use flashcards and multiple choice questions, each with hints and detailed explanations. Start studying today!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which treatment is indicated for neuroleptic malignant syndrome?

  1. Antidepressants

  2. Dantrolene

  3. Beta-blockers

  4. Antihistamines

The correct answer is: Dantrolene

Neuroleptic Malignant Syndrome (NMS) is a potentially life-threatening condition that can occur in response to antipsychotic medications, characterized by symptoms such as muscle rigidity, high fever, autonomic instability, and altered mental status. The treatment for NMS focuses on addressing the hypermetabolic state and alleviating the symptoms. Dantrolene is indicated for use in NMS as it works by directly inhibiting calcium release in muscle cells, thus helping to relieve muscle rigidity and lower the elevated body temperature associated with this syndrome. Its role is particularly emphasized in cases of severe rigidity and hyperthermia that may occur in patients with NMS. Other options like antidepressants, beta-blockers, and antihistamines do not target the underlying pathophysiology of NMS effectively. While beta-blockers may have some use in managing autonomic symptoms, they do not directly treat NMS itself. Antihistamines and antidepressants are primarily used for different conditions and would not provide the necessary intervention for this acute syndrome. Therefore, the use of dantrolene is recognized as a crucial component in the management of neuroleptic malignant syndrome.